High Content Screening/Imaging: Technologies and Global Markets

Report Highlights

The global market for high content screening/imaging technology should grow from $1.2 billion in 2021 to $2.3 billion by 2026 with a compound annual growth rate (CAGR) of 13.5% for the period of 2021-2026.

Report Includes

• 44 data tables and 28 additional tables
• An overview of the global markets and technologies for high content screening/imaging
• Estimation of the market size and analyses of market trends, with data from 2019, 2020, estimates for 2021 and projection of CAGR through 2026
• Quantification of high content screening/imaging market based on component, end user, application, and region, and analysis of market drivers, restraints and other forces impacting the global market
• Highlights of the current and future market potential, detailed analysis of the regulatory framework and policies and information on new technologies and innovations of the industry
• Discussion on advantages of high-throughput screening over manual screening, and COVID-19 impact on MedTech and medical tourism
• Coverage of recent developments, research and development (R&D) exploration, clinical trials and government programs to predict market trends of the HCS/I market
• Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
• Company profiles of major players, including Molecular Devices (Danaher), Thermo Fisher Scientific, Becton, Dickinson and Co., PerkinElmer Inc., Genedata AG, and Yokogawa Electric Corp.

Report Scope

The current report offers a detailed picture of the high content screening/imaging market.

This report highlights the current and future market potential for high content screening/imaging and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2026, as well as key market players.

This report discusses the high content screening/imaging industry and its various resources. It covers the overall high content screening/imaging market including instrument or platform, consumables (reagents and kits), software and analytics, and services. The report further analyzes the market based on application, providing an analysis of drug discovery, oncology, compound profiling, molecular diagnosis, toxicity studies and neuroscience. A complete regional analysis of the market is also studied in the report.

Based on geography, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World (which includes Latin America, and the Middle East and Africa). Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2020 as the base year, with forecasts for 2021 through 2026. Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

• Hydrogen Fuel Cell: Global Markets (EGY186B)
• Cell and Gene Therapy Tools, and Reagents: Global Markets (BIO208C)
• Single-use Technologies for Biopharmaceuticals: Global Markets (BIO099F)
• Induced Pluripotent Stem Cells: Global Markets (BIO135F)
• Commercial Amino Acids (BIO007N)